A randomized clinical trial in the management of Ardhavabhedaka to review the principle - “Nasa Hi Shiraso Dwaram”

Abstract

Background: The purpose of Ayurveda as a medical system is to ensure a healthier and longer life to the humanity. Awareness about its holistic approach, its natural and mostly safe methods, and its potential for maintaining health is increasing globally. Ardhavabhedaka is a disease of Shiroroga, charecterised by pain in half side of Shira, Shankha, Akshi, Karna, Bru, Lalatavedana. It is a common clinical problem which occurs by episodic attacts of headache and associated symptoms such as nausea, sensitivity to light, sound, cold and head movements. Nasa is the gateway of Shira. The drug administered through nose as Nasya reaches the brain and eliminates only morbid Doshas responsible for producing the diseases of Urdhvajatrugatapradesha. The objectives were to study in detail about Nasa Hi Shirasodwaram, Gudadi Nasya in Ardhavabhedaka from Ayurvedic view and to evaluate the efficacy of Gudadi Nasya from Sharangadhara Samhita in management of Ardhavabhedaka. Methods: Total 30 subjects, having symptoms of Ardhavabhedaka were included. 30 subjects were assigned in a single group and all subjects were administered with Gudadi Nasya for 7 days 45 days follow up was done. Results were staticstically analysed before and after treatment by using unpaired ‘t’ test. Results: Among 30 subjects studied, 17 subjects showed marked relief, 11 subjects showed moderate relief and 02 subjects showed mild relief in the overall treatment.